Bloomberg: J&J agrees to pay about $1 billion to resolve hip implant lawsuits
Posted on May 07, 2019 by Medtech[y] Staff
On Tuesday, Bloomberg reported that Johnson & Johnson (JNJ) has agreed to pay approximately $1 billion to resolve 95% of the 6000 lawsuits claiming JNJ sold defective metal-on-metal Pinnacle hip implants which ultimately had to be removed.
JNJ's Orthopedics division, Depuy, stopped selling the Pinnacle metal-on-metal implants in 2013 once the FDA strengthened regulations on artificial hips. The company continues to sell Pinnacle hips that use other materials.
The Pinnacle implants caused severe injuries with patients unable to walk and in pain as the implants potentially caused a buildup of metal ions in the blood. This resulted in tissue death, groin pain, bone erosion and allergic reactions.
The full Bloomberg report can be read here.
Are you a recruiter or company looking to fill a Medical Sales opening, including the medical device or biotech industries? If so, checkout Medtechy Jobs and create a free employer account or a free candidate account. All of our jobs are strategically distributed to our diverse following of experienced and those new to the industry. Multi-pack jobs start at $100.
We are also excited to launch Medtechy Deals, our new store which sources deals on gadgets, everyday carry essentials and online courses for employees in the healthcare industry!
Please follow us on Facebook, Twitter, and LinkedIn for the latest medical technology news, medical device/biotech company intel and career opportunities. You can also sign up for our monthly newsletter.